
Humira: An injected biologic for moderate to severe plaque psoriasis. It blocks TNF, one of the main inflammation signals behind psoriasis, and is usually given as a shot under the skin every other week. Mometasone: A mid-strength prescription steroid applied once a day for eczema, psoriasis and other itchy rashes. Strong enough to settle a flare, measured enough for short courses on most of the body.


Choose for moderate to severe psoriasis or hidradenitis suppurativa — the first approved biologic for HS, now with cheaper biosimilars.
Choose to settle an eczema or psoriasis flare on the body with a once-daily, mid-strength steroid.
Can you take them together?
Mometasone is often used on remaining stubborn patches while on Humira. It does not interact with the biologic.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.











Binds TNF: Captures an immune messenger that promotes inflammation. Reduces inflammatory signaling: TNF has less ability to activate its receptors. Lets inflamed skin settle: Conditions such as psoriasis can improve over time.
Adalimumab binds TNF-alpha and inhibits its interaction with p55/p75 TNF receptors. This image focuses on skin inflammation; Humira also has other indications.

Activates steroid receptors: Binds receptors inside skin and immune cells. Turns down inflammatory signals: Changes gene activity to reduce inflammatory messengers. Eases redness and itch: Swelling and irritation settle as inflammation falls.
Simplified glucocorticoid receptor-mediated effects in steroid-responsive skin inflammation. Full effects also involve other pathways. No claim of antimicrobial action or cure; formulation and potency affect clinical use.
Adults are not dosed by body weight. You start with a larger loading dose to get levels up fast, then settle into an every-other-week rhythm.
Starting dose: 80 mg on day one, as one 80 mg injection or two 40 mg injections at different spots.
One week later: 40 mg.
Usual dose: 40 mg every other week, the same day of the week each time.
If it stops working: Some people move to weekly injections, others switch drugs. The prescriber's call.
Other conditions: Hidradenitis suppurativa uses a heavier loading dose and weekly maintenance, so do not assume a friend's schedule matches yours.
How long: Long term, with no set course length. It continues while it works and is tolerated.
When to Apply: Once a day, a thin film on the rash only, not the skin around it. A fingertip length covers roughly two flat palms. Moisturizer can go on the same skin at other times.
How to Start: Once daily from day one until the skin is smooth and not itchy, usually a few days to two weeks. Under-using it is the commoner mistake. Then stop, or step down to twice a week if your doctor set that up.
If It Irritates: A short sting on cracked or raw skin is common and settles as the skin heals. Moisturizing twenty minutes before or after helps. Burning that worsens over days can mean infection, a reaction to the base, or the wrong diagnosis.
If It’s Not Working: Two weeks of daily use with no change means something else is going on — too little applied, a fungal or infected rash that steroids make worse, or a rash needing a stronger cream or a different drug. Do not keep going past that without a review.
Any time of day, but pick a set day of the week and keep to it. Every other week is easy to lose track of, so set a phone reminder on day one.
Take the pen or syringe out of the fridge 15 to 30 minutes before injecting. Cold liquid stings more. Do not warm it in the microwave or hot water.
Inject into the front of the thigh or the belly, at least two inches from the navel. Rotate the spot each time, and avoid skin that is bruised, red, hard, tender or scarred. Never inject through a plaque. A nurse or pharmacist should train you in person for the first dose. Used pens go in a sharps container, never the household bin.
Inject as soon as you remember, then return to your original schedule rather than shifting future doses. Never inject two doses to catch up. If you have missed more than one dose, call the prescriber before restarting — long gaps can blunt how well it works.
Everyone is screened for tuberculosis before the first dose — a skin test or TB blood test, often with a chest X-ray. TNF blockers can wake a dormant TB infection, so a positive screen is treated first and adalimumab waits until that treatment is under way. Testing is often repeated yearly, or sooner if you live somewhere TB is common.
Hepatitis B and C are checked too, because hepatitis B can reactivate when the immune signal is blocked.
After that there is no fixed blood test schedule like methotrexate's. Many doctors check a blood count and liver tests occasionally. Most monitoring is clinical — how the skin looks, and whether you are getting more infections than usual.
Skin should be checked periodically, because TNF blockers are linked to a small increase in skin cancer. The label also carries a boxed warning about serious infections and about lymphoma and other cancers, based mostly on rare cases in children and young adults. The absolute risk is low, but it is why this prescription gets regular review.
No blood tests for ordinary use. Monitoring is looking at the skin: is the treated area thinner or shinier than the skin beside it, are small veins showing, are there stretch marks in the folds or pus bumps around hair follicles.
The exception is large-area, long-term or covered use, and use in small children, where enough can be absorbed to affect the body’s own steroid production. Uncommon, and why a doctor sets an area and a time limit.
The checkpoint is a review at two to four weeks. Using it most weeks over months means the question is no longer the cream but what long-term treatment should be doing this job.
Approximate windows, not promises.
First few minutesThe injection: A sting for a few seconds. Injection site reactions, if they happen, show up in the first weeks.
First few minutesApplying it: A thin layer once a day, on the affected skin only.
Weeks 1 to 4Starting: Itching often eases before the plaques look different, and some people see the scale thin early.
Weeks 4 to 12Working: Plaques flatten, scale lifts and redness fades from the middle outward. Most of the visible change happens here. Psoriatic arthritis improves on a similar timeline, and hidradenitis suppurativa settles to fewer painful lumps on its own heavier schedule.
Week 16Judge it here: The point the trials measured. Most people reached at least a 75 percent improvement in skin involvement and severity, and a smaller share cleared almost completely.
Months 6 to 12Nails: The slowest, because a nail takes months to grow out. Pitting and lifting improve well after the skin has settled.
After the first yearLong term: Most people who respond keep responding.
Days 1 to 3Itch first: Itch eases before the rash looks different. Normal, and not a reason to add more.
Days 3 to 14Working: Redness fades, scale flattens, weeping stops. Most short courses finish here, and moisturizer keeps going after the steroid stops.
Weeks 2 to 4Judge it here: If it is clear, stop or move to twice-weekly maintenance.
Weeks 2 to 6Psoriasis plaques: Scale lifts and plaques flatten. Something else usually runs alongside, since steroids rarely hold psoriasis on their own.
Weeks to monthsThickened, leathery patches: Skin rubbed and scratched for a long time takes longest, because the thickening itself has to reverse.
Beyond a few weeks of continuous useThe risks: Thinning skin, visible small veins, stretch marks in folds, small pus bumps around hair follicles. Uncommon on short courses, and why long courses are planned rather than drifted into.
Sorted by what to do about them.
The list price is very high, tens of thousands of dollars a year. Almost nobody pays that. What you pay depends on your insurance, and getting there takes paperwork.
Prior authorization is close to universal. Most plans require you to have tried and failed something cheaper first — phototherapy, methotrexate or another systemic drug — and they want records to prove it.
Biosimilars changed the picture. Several have been sold in the United States since 2023, some at much lower list prices. Which one you get is usually decided by your plan's formulary, not your dermatologist, and plans switch year to year. A switch is a paperwork event, not a medical downgrade, though you may need retraining on a different pen.
Manufacturer copay cards can bring the cost down to very little with commercial insurance. By law they cannot be used with Medicare or Medicaid. For those plans, or with no insurance, manufacturer and foundation assistance programs are the usual route, and their rules change often.
Generic mometasone is inexpensive and widely stocked, and the cream and ointment are on most low-cost generic lists. The Elocon brand costs considerably more for the same molecule.
The lotion and scalp solution usually cost more, and are sometimes the versions a plan will not cover. If cost is the issue, ask whether a different base at the same 0.1% would do the job.
A large protein grown in living cells rather than a factory chemical. That is why it is injected, and why it lives in the fridge.
A sharp sting for a few seconds. Letting it warm to room temperature first makes a real difference, and citrate-free versions sting less than the original.
Some change by 4 weeks, and about 16 weeks before you judge it fairly. If nothing has happened by then, talk about switching.
Yes, apart from live ones. The flu shot, COVID, pneumonia vaccines and Shingrix are fine and usually recommended. Have live vaccines before you start.
A simple cold is usually not a reason to skip a dose. Anything with a fever, or needing antibiotics, should be checked with the prescriber first.
It must be shown to have no clinically meaningful difference from the original. The pen changes; what is inside does the same job.
Two to four weeks on a defined area. Longer should be your doctor's decision, usually as twice-weekly maintenance.
Only if your doctor said so, and briefly. Facial skin absorbs far more and shows thinning first. Milder or non-steroid creams are usually chosen there.
Yes, and you should — at a different time of day, so you are not diluting the steroid or spreading it beyond the rash.
The steroid treated the inflammation, not the cause. Expected in eczema and psoriasis, and why maintenance and steady moisturizing matter.
Yes. It was developed for once-daily use and the trials were done that way. Twice a day adds side effect risk without benefit.
A short sting on broken skin is common and settles. Burning that builds over days, or a worsening rash, can mean infection or a reaction to the base.